Suanfarma Suanfarma

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find the latest Drugs in Development and Pipeline Prospector News of Advanced Bioscience laboratories.

    Client Virtual Booth

    ADVANCED BIOSCIENCE LABORATORIES

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    Advanced Bioscience laboratories
    United_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    9800 Medical Center Drive, Building D Rockville, MD 20850
    Telephone
    Telephone
    800-225-5600
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://ablinc.com/
    Linkedin
    Linkedin
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    • Deals
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE

    GeoVax Partners With ABL to Advance cGMP Production of Vaccine Candidates

    Details:

    The partnership will support current Good Manufacturing Practices production of the company’s vaccine candidates, including GEO-MVA and GEO-CM04S1 (MVA-based SARS-CoV-2 vaccine), a next-generation COVID-19 vaccine based on GeoVax’s MVA viral vector platform.


    Lead Product(s): MVA-based SARS-CoV-2 Vaccine

    Therapeutic Area: Oncology Product Name: GEO-CM04S1

    Highest Development Status: Phase IIProduct Type: Vaccine

    Recipient: GeoVax Labs

    Deal Size: Undisclosed Upfront Cash: Undisclosed

    Deal Type: Agreement May 31, 2023

    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content
    • Deals
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE

    ABL Awarded NIH Contract for Continued Support of HIV Vaccine Development

    Details:

    ABL will provide DAIDS with preclinical and translational development of promising vaccines and related products for HIV and other candidate agents.


    Lead Product(s): HIV-1 Vaccine

    Therapeutic Area: Infections and Infectious Diseases Product Name: Undisclosed

    Highest Development Status: PreclinicalProduct Type: Vaccine

    Partner/Sponsor/Collaborator: DAIDS

    Deal Size: $364.5 million Upfront Cash: Undisclosed

    Deal Type: Partnership October 20, 2022

    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    fermion-oy-2024-05-13

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search